genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2023
Fragile X syndrome
News
A Leading Cause of Autism Spectrum Disorders May Be Prevented by Novel Approach
Christina Jackson
-
May 21, 2023
0
News
Fragile X Protein Regulates GABA-A Receptors in the Hippocampus
Julianna LeMieux, PhD
-
May 18, 2022
0
News
Researchers Discover a Link between Primary Cilia and Fragile X Syndrome
Christina Jackson
-
July 31, 2020
0
Insights
New CRISPR Startups Get a Leg Up
Brandon May
-
July 31, 2018
0
News
Fragile X Symptoms May be Helped with New Pharmacological Approach
GEN Staff Writer
-
July 16, 2018
0
Industry News
Zynerba Scraps Development of THC Prodrug ZYN001 after Failed Trial
GEN Staff Writer
-
July 5, 2018
0
Genome Editing
Editing Autism Gene with Nano-CRISPR Curbs Repetitive Behaviors
GEN Staff Writer
-
June 27, 2018
0
News
Autism Protein Epigenetically Misregulated Study Finds, Opening Door for New Treatments
GEN Staff Writer
-
September 29, 2017
0
Industry News
Alcobra ADHD Candidate MDX Fails Phase III Trial
GEN Staff Writer
-
January 17, 2017
0
Drug Discovery
Fulcrum Therapeutics Launched with Robert Gould at Helm
GEN Staff Writer
-
July 19, 2016
0
1
2
3
Page 1 of 3
Scroll Up
Scroll Up
